Brielle Benyon, Assistant Managing Editor for CURE®, has been with MJH Life Sciences since 2016. She has served as an editor on both CURE and its sister publication, Oncology Nursing News. Brielle is a graduate from The College of New Jersey. Outside of work, she enjoys spending time with family and friends, CrossFit and wishing she had the grace and confidence of her toddler-aged daughter.
Follow Brielle on Twitter @Brielle_Benyon.
Patient Awarded $289 Million in Landmark Monsanto-Associated Cancer Case
August 13th 2018Dewayne Johnson, a patient with cancer who claimed that Monsanto’s Roundup product was at the root of his non-Hodgkin lymphoma diagnosis in 2014, was awarded $289 million by a jury, as reported by the Associated Press.
Read More
Two Large Trials Investigate Combination Immunotherapy in Bladder Cancer
July 31st 2018With five immunotherapy drugs approved in the bladder cancer space, the next question researchers find themselves asking is whether these drugs would work better alone or as part of a combination for patients with metastatic disease.
Read More
Genetic Mutation Can Predict Acute Myeloid Leukemia Risk a Decade Before Diagnosis
July 17th 2018While there are known risk factors of developing acute myeloid leukemia (AML) – such as a myelodysplastic syndrome diagnosis and receiving chemotherapy and radiotherapy – a diagnosis can still stun and individual. But researchers at Weill Cornell Medicine and New York-Presbyterian recently discovered a genomic pre-malignant biomarker of the disease that can identify people who are at a greater risk for AML.
Read More
Cramps or Cancer: Elevated Menstrual Pain May be Associated with Ovarian Cancer Risk
July 17th 2018Researchers reviewed the cases of more than 20,000 women – some who went on to develop ovarian cancer, and some who didn’t – and found that there was a small, but statistically significant increase in ovarian cancer incidence in women who reported having severe menstrual pain.
Read More
Pre-Surgical Bladder Cancer Treatment: What's Next
July 16th 2018Many questions still remain in the treatment of localized bladder cancer, like which patients are best suited to receive neoadjuvant (pre-surgery) chemotherapy – a procedure that could be beneficial to many, but comes with increased toxicity.
Read More
A Closer Look at Long-Term Outcomes in Young Cancer Survivors
July 10th 2018The majority of adolescent and young adult (AYA) patients who are diagnosed with cancer are expected to live past the five-year mark, though survival and health outcomes seem to differ by disease type, according to recent research published in the journal Cancer.
Read More
Cancer Rates 'Soar' in Flight Crew Compared with General Population
July 4th 2018While having a career as a flight attendant allows individuals to travel the globe, exposure to carcinogens and frequent disruptions in circadian rhythms may increase cancer prevalence in these individuals, according to recent research published in the journal Environmental Health.
Read More
Examining Early-Life Adversity and the 'Stress Hormone' in Ovarian Cancer Survivors
July 3rd 2018Adversity early on in life and increased stress levels could impact ovarian cancer outcomes – even if these instances happen before a woman is diagnosed, according to a recent article published in the journal Cancer.
Read More
Lynparza Prolongs Disease Progression in Advanced Ovarian Cancer
June 29th 2018PARP inhibitors continue to impress in the ovarian cancer space, as findings from the recent phase 3 SOLO-1 trial showed that Lynparza (olaparib) showed clinically-meaningful improvement in progression-free survival (PFS) when used in the first-line maintenance setting.
Read More